[Federal Register Volume 88, Number 174 (Monday, September 11, 2023)]
[Notices]
[Pages 62385-62386]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-19542]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the CDC/HRSA Advisory Committee on HIV, Viral 
Hepatitis and STD Prevention and Treatment

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Secretary's Centers for Disease Control and 
Prevention (CDC)/HRSA Advisory Committee on HIV, Viral Hepatitis and

[[Page 62386]]

STD Prevention and Treatment (CHAC) has scheduled a public meeting. 
Information about CHAC and the meeting can be found on the CHAC website 
at https://www.cdc.gov/faca/committees/chachspt.html and the meeting 
website at https://targethiv.org/ta-org/chac.

DATES: Tuesday, October 24, 2023, 9 a.m. to 4 p.m. Eastern Time (ET); 
and Wednesday, October 25, 2023, 9 a.m. to 3 p.m. ET.

ADDRESSES: This meeting will be hybrid, held both virtually through 
Zoom and in person at 5600 Fishers Lane, Pavilion Rooms 5A02, 5A03, and 
5A04, Rockville, Maryland 20857. Advance registration is required to 
attend. Please visit the meeting website to register. The in-person 
registration deadline is Monday, October 16, 2023, at 5 p.m. ET; 
registration for virtual attendance will remain open. Prior to the 
meeting, each individual registrant will receive a registration 
confirmation along with an access link to the virtual meeting location.

FOR FURTHER INFORMATION CONTACT: Shalonda Collins, Public Health 
Analyst, HIV/AIDS Bureau, HRSA, (301) 945-0835; 
<a href="/cdn-cgi/l/email-protection#8dcec5cccecce9fbe4fee2fff4cee2e0e0cde5fffeeca3eae2fb"><span class="__cf_email__" data-cfemail="6b28232a282a0f1d0218041912280406062b0319180a450c041d">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: CHAC provides advice and recommendations to 
the Secretary of HHS (Secretary) on policy, program development, and 
other matters of significance concerning the activities under Section 
222 of the Public Health Service Act, 42 U.S.C. 217a.
    The purpose of the CHAC is to advise the Secretary of HHS, CDC 
Director, and HRSA Administrator regarding objectives, strategies, 
policies, and priorities for the prevention and treatment of HIV, viral 
hepatitis, and other STDs, including surveillance, epidemiologic, 
behavioral, health services, and laboratory research, identification of 
policy issues related to professional eduction, patient healthcare 
delivery, and prevention services; agency policies regarding health 
care delivery, research and training; strategic issues influencing the 
ability of CDC and HRSA to fulfill their missions' programmatic efforts 
to prevent and treat HIV, viral hepatitis, and other STDs; and support 
to CDC and HRSA in their development of responses to emerging health 
needs related to these issues.
    During the October 24-25, 2023, meeting, CHAC will discuss issues 
related to reducing barriers and improving outcomes in HIV and 
Hepatitis C co-infection, payment models for addressing social 
determinants of health, incorporating stigma reduction in HIV care and 
treatment, as well as other special presentations. Agenda items are 
subject to change as priorities dictate. Refer to the CHAC meeting 
information page for any updated information concerning the meeting.
    Members of the public will have the opportunity to provide 
comments. Public participants may also submit written statements as 
further described below. Oral comments will be honored in the order 
they are requested and may be limited as time allows. Requests to 
submit a written statement or make oral comments to CHAC should be sent 
via the meeting website at https://targethiv.org/ta-org/chac. Requests 
for oral comment must be received by October 17, 2023, at 5 p.m. ET to 
be considered. Written comments may be submitted to Shalonda Collins at 
the email address and/or phone number listed above prior to and up to 
10 business days after the meeting. Visit the meeting information page 
for additional details: https://targethiv.org/ta-org/chac.
    Individuals who plan to attend and need special assistance or 
another reasonable accommodation should notify Shalonda Collins at the 
email address and/or phone number listed above at least 10 business 
days prior to the meeting.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023-19542 Filed 9-8-23; 8:45 am]
BILLING CODE 4165-15-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>